Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial

DiscussionThis is the first study, to the best of our knowledge, to determine the optimal target level of serum UA for renal protection and is expected to lead to progress in CKD treatment.Trial registration(UMIN000026741 and jRCTs051180146).
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research